Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults

Go back to Resources

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

History of clinical trials

Go back to Resources

History of clinical trials

Authors:

Secondary:

Location:

Publisher:

Go back to Resources

Growth post-renal transplantation in children: 11 year North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) report.

Go back to Resources

Growth post-renal transplantation in children: 11 year North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) report.

Authors:

Location:

Go back to Resources

For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): The impact of donor source, pre-operative immunotherapy and prophylactic antibody therapy on first rejection episodes in children.

Go back to Resources

For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): The impact of donor source, pre-operative immunotherapy and prophylactic antibody therapy on first rejection episodes in children.

Authors:

Location:

Go back to Resources

For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Quality of life of children post-transplantation compared to children on dialysis.

Go back to Resources

For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Quality of life of children post-transplantation compared to children on dialysis.

Authors:

Location:

Go back to Resources

Fecal occult blood screening in the Minnesota Study. Letter

Go back to Resources

Fecal occult blood screening in the Minnesota Study. Letter

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Effect of parental donor sex on rejection in pediatric renal transplantation: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Go back to Resources

Effect of parental donor sex on rejection in pediatric renal transplantation: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Dramatic improvement in cadaver donor graft survival of North American children.

Go back to Resources

Dramatic improvement in cadaver donor graft survival of North American children.

Authors:

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases.

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases.

Authors:

Location:

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases

Authors:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • Current page 113
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions